[go: up one dir, main page]

GB201113729D0 - Hyperlipidaemia - Google Patents

Hyperlipidaemia

Info

Publication number
GB201113729D0
GB201113729D0 GBGB1113729.6A GB201113729A GB201113729D0 GB 201113729 D0 GB201113729 D0 GB 201113729D0 GB 201113729 A GB201113729 A GB 201113729A GB 201113729 D0 GB201113729 D0 GB 201113729D0
Authority
GB
United Kingdom
Prior art keywords
hyperlipidaemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1113729.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocopea Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Priority to GBGB1113729.6A priority Critical patent/GB201113729D0/en
Publication of GB201113729D0 publication Critical patent/GB201113729D0/en
Priority to PCT/GB2012/050242 priority patent/WO2012104655A2/en
Priority to CA2826506A priority patent/CA2826506C/en
Priority to MX2013008851A priority patent/MX346224B/en
Priority to SG2013059365A priority patent/SG192621A1/en
Priority to RU2016138830A priority patent/RU2016138830A/en
Priority to EP12704295.0A priority patent/EP2670389A1/en
Priority to NZ613805A priority patent/NZ613805B2/en
Priority to MX2013008850A priority patent/MX364229B/en
Priority to CN201280007753.4A priority patent/CN103391767B/en
Priority to EP24176682.3A priority patent/EP4397373A3/en
Priority to SG2013059357A priority patent/SG192620A1/en
Priority to BR112013019734A priority patent/BR112013019734A2/en
Priority to SG10201600854SA priority patent/SG10201600854SA/en
Priority to JP2013552271A priority patent/JP2014507429A/en
Priority to JP2013552272A priority patent/JP2014504629A/en
Priority to EP18213159.9A priority patent/EP3494961B1/en
Priority to US13/365,824 priority patent/US8895536B2/en
Priority to US13/365,828 priority patent/US8895537B2/en
Priority to RU2013140775/15A priority patent/RU2013140775A/en
Priority to AU2012213218A priority patent/AU2012213218C1/en
Priority to AU2012213217A priority patent/AU2012213217B2/en
Priority to RU2013140776A priority patent/RU2635188C2/en
Priority to PCT/GB2012/050241 priority patent/WO2012104654A1/en
Priority to NZ711187A priority patent/NZ711187B2/en
Priority to EP12704296.8A priority patent/EP2670390A2/en
Priority to CN201280007770.8A priority patent/CN103391768B/en
Priority to NZ613812A priority patent/NZ613812B2/en
Priority to ES18213159T priority patent/ES2981782T3/en
Priority to CA2826452A priority patent/CA2826452C/en
Priority to BR112013019732-3A priority patent/BR112013019732B1/en
Priority to ZA2013/05784A priority patent/ZA201305784B/en
Priority to ZA2013/05783A priority patent/ZA201305783B/en
Priority to US14/155,108 priority patent/US9308213B2/en
Priority to US14/155,080 priority patent/US9265742B2/en
Priority to US14/155,167 priority patent/US10695432B2/en
Priority to US14/155,042 priority patent/US9271950B2/en
Priority to US14/155,147 priority patent/US10695431B2/en
Priority to US14/520,159 priority patent/US9427422B2/en
Priority to US14/520,150 priority patent/US9381180B2/en
Priority to US14/520,141 priority patent/US9326958B2/en
Priority to US14/821,687 priority patent/US9744132B2/en
Priority to US14/975,599 priority patent/US9504664B2/en
Priority to US14/975,608 priority patent/US9737500B2/en
Priority to JP2016015164A priority patent/JP6273304B2/en
Priority to US15/043,327 priority patent/US9750810B2/en
Priority to US15/061,661 priority patent/US9775820B2/en
Priority to US15/169,619 priority patent/US10004704B2/en
Priority to US15/169,617 priority patent/US9693980B2/en
Priority to US15/195,608 priority patent/US9820952B2/en
Priority to US15/195,623 priority patent/US9827215B2/en
Priority to US15/219,245 priority patent/US9789075B2/en
Priority to US15/289,083 priority patent/US20170043016A1/en
Priority to US15/295,933 priority patent/US9795577B2/en
Priority to US15/614,592 priority patent/US10155042B2/en
Priority to US15/684,214 priority patent/US10213381B2/en
Priority to US15/684,197 priority patent/US10363232B2/en
Priority to US15/702,440 priority patent/US10231943B2/en
Priority to US15/794,178 priority patent/US10188619B2/en
Priority to US15/794,197 priority patent/US10154975B2/en
Priority to US15/794,214 priority patent/US10143671B2/en
Priority to US16/012,036 priority patent/US10426748B2/en
Priority to US16/166,272 priority patent/US10596132B2/en
Priority to US16/206,789 priority patent/US10653778B2/en
Priority to US16/206,814 priority patent/US10588878B2/en
Priority to US16/284,221 priority patent/US10835490B2/en
Priority to US16/525,520 priority patent/US10857114B2/en
Priority to US16/573,776 priority patent/US10849869B2/en
Priority to US16/729,363 priority patent/US20200129461A1/en
Priority to US16/818,668 priority patent/US11000493B2/en
Priority to US16/882,663 priority patent/US11154500B2/en
Priority to US16/882,667 priority patent/US11224659B2/en
Priority to US16/882,666 priority patent/US11202831B2/en
Priority to US17/107,724 priority patent/US11660276B2/en
Priority to US17/113,476 priority patent/US11730709B2/en
Priority to US17/146,989 priority patent/US11103472B2/en
Priority to US17/146,950 priority patent/US11065218B2/en
Priority to US17/230,855 priority patent/US11844773B2/en
Priority to US17/378,744 priority patent/US20210338617A1/en
Priority to US17/448,263 priority patent/US11992555B2/en
Priority to US17/540,802 priority patent/US11826428B2/en
Priority to US17/646,241 priority patent/US11918654B2/en
Priority to US18/509,114 priority patent/US12533332B2/en
Priority to US18/595,716 priority patent/US20240207408A1/en
Priority to US18/641,775 priority patent/US20240277613A1/en
Ceased legal-status Critical Current

Links

GBGB1113729.6A 2010-10-29 2011-08-10 Hyperlipidaemia Ceased GB201113729D0 (en)

Priority Applications (85)

Application Number Priority Date Filing Date Title
GBGB1113729.6A GB201113729D0 (en) 2011-08-10 2011-08-10 Hyperlipidaemia
PCT/GB2012/050242 WO2012104655A2 (en) 2011-02-04 2012-02-03 Compostions and methods for treating chronic inflammation and inflammatory diseases
CA2826506A CA2826506C (en) 2011-02-04 2012-02-03 Compositions and methods for treating chronic inflammation and inflammatory diseases
MX2013008851A MX346224B (en) 2011-02-04 2012-02-03 Compostions and methods for treating chronic inflammation and inflammatory diseases.
SG2013059365A SG192621A1 (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular diseases
RU2016138830A RU2016138830A (en) 2011-02-04 2012-02-03 COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASES
EP12704295.0A EP2670389A1 (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular diseases
NZ613805A NZ613805B2 (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular diseases
MX2013008850A MX364229B (en) 2011-02-04 2012-02-03 COMPOSITIONS and METHODS FOR TREATING CARDIOVASCULAR DISEASES.
CN201280007753.4A CN103391767B (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular disease
EP24176682.3A EP4397373A3 (en) 2011-02-04 2012-02-03 Pharmaceutical compositions comprising cannabinoids
SG2013059357A SG192620A1 (en) 2011-02-04 2012-02-03 Compostions and methods for treating chronic inflammation and inflammatory diseases
BR112013019734A BR112013019734A2 (en) 2011-02-04 2012-02-03 compositions and methods for treating chronic inflammation and inflammatory diseases
SG10201600854SA SG10201600854SA (en) 2011-02-04 2012-02-03 Compostions And Methods For Treating Chronic Inflammation And Inflammatory Diseases
JP2013552271A JP2014507429A (en) 2011-02-04 2012-02-03 Compositions and methods for the treatment of cardiovascular disease
JP2013552272A JP2014504629A (en) 2011-02-04 2012-02-03 Compositions and methods for treating chronic inflammation and inflammatory diseases
EP18213159.9A EP3494961B1 (en) 2011-02-04 2012-02-03 Compositions and methods for treating chronic inflammation and inflammatory diseases
US13/365,824 US8895536B2 (en) 2010-10-29 2012-02-03 Compositions and methods for treating chronic inflammation and inflammatory diseases
US13/365,828 US8895537B2 (en) 2010-10-29 2012-02-03 Compositions and methods for treating cardiovascular diseases
RU2013140775/15A RU2013140775A (en) 2011-02-04 2012-02-03 COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISEASES
AU2012213218A AU2012213218C1 (en) 2011-02-04 2012-02-03 Compostions and methods for treating chronic inflammation and inflammatory diseases
AU2012213217A AU2012213217B2 (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular diseases
RU2013140776A RU2635188C2 (en) 2011-02-04 2012-02-03 Compositions and methods for treatment of chronic inflammation and inflammatory diseases
PCT/GB2012/050241 WO2012104654A1 (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular diseases
NZ711187A NZ711187B2 (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular disease
EP12704296.8A EP2670390A2 (en) 2011-02-04 2012-02-03 Compostions and methods for treating chronic inflammation and inflammatory diseases
CN201280007770.8A CN103391768B (en) 2011-02-04 2012-02-03 Treat chronic inflammatory disease and the compositions of inflammatory diseases and method
NZ613812A NZ613812B2 (en) 2011-02-04 2012-02-03 Compositions and methods for treating chronic inflammation and inflammatory diseases
ES18213159T ES2981782T3 (en) 2011-02-04 2012-02-03 Compositions and methods for treating chronic inflammation and inflammatory diseases
CA2826452A CA2826452C (en) 2011-02-04 2012-02-03 Compositions and methods for treating cardiovascular diseases
BR112013019732-3A BR112013019732B1 (en) 2011-02-04 2012-02-03 PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
ZA2013/05784A ZA201305784B (en) 2011-02-04 2013-07-31 Compositions and methods for treating chronic inflammation and inflammatory diseases
ZA2013/05783A ZA201305783B (en) 2011-02-04 2013-07-31 Composition and methods for treating cardiovascular diseases
US14/155,108 US9308213B2 (en) 2010-10-29 2014-01-14 Solid solution compositions and use in chronic inflammation
US14/155,080 US9265742B2 (en) 2010-10-29 2014-01-14 Compositions and methods for treating inflammatory pain
US14/155,167 US10695432B2 (en) 2010-10-29 2014-01-14 Solid solution compositions and use in severe pain
US14/155,042 US9271950B2 (en) 2010-10-29 2014-01-14 Compositions for treating chronic inflammation and inflammatory diseases
US14/155,147 US10695431B2 (en) 2010-10-29 2014-01-14 Solid solution compositions and use in cardiovascular disease
US14/520,159 US9427422B2 (en) 2010-10-29 2014-10-21 Compositions for treating cardiovascular diseases
US14/520,150 US9381180B2 (en) 2010-10-29 2014-10-21 Compositions and methods for treating chronic inflammation and inflammatory diseases
US14/520,141 US9326958B2 (en) 2010-10-29 2014-10-21 Compositions for treating chronic inflammation and inflammatory diseases
US14/821,687 US9744132B2 (en) 2010-10-29 2015-08-07 Solid solution compositions and use in chronic inflammation
US14/975,599 US9504664B2 (en) 2010-10-29 2015-12-18 Compositions and methods for treating severe pain
US14/975,608 US9737500B2 (en) 2010-10-29 2015-12-18 Compositions and methods for treating severe pain
JP2016015164A JP6273304B2 (en) 2011-02-04 2016-01-29 Compositions and methods for treating chronic inflammation and inflammatory diseases
US15/043,327 US9750810B2 (en) 2010-10-29 2016-02-12 Compositions and methods for treating chronic inflammation and inflammatory diseases
US15/061,661 US9775820B2 (en) 2010-10-29 2016-03-04 Solid solution compositions and use in chronic inflammation
US15/169,619 US10004704B2 (en) 2010-10-29 2016-05-31 Compositions and methods for treating chronic inflammation and inflammatory diseases
US15/169,617 US9693980B2 (en) 2010-10-29 2016-05-31 Compositions and methods for treating chronic inflammation and inflammatory diseases
US15/195,608 US9820952B2 (en) 2010-10-29 2016-06-28 Solid solution compositions and use in chronic inflammation
US15/195,623 US9827215B2 (en) 2010-10-29 2016-06-28 Solid solution compositions and use in chronic inflammation
US15/219,245 US9789075B2 (en) 2010-10-29 2016-07-25 Compositions and methods for treating cardiovascular diseases
US15/289,083 US20170043016A1 (en) 2010-10-29 2016-10-07 Solid Solution Compositions and Use in Severe Pain
US15/295,933 US9795577B2 (en) 2010-10-29 2016-10-17 Compositions and methods for treating severe pain
US15/614,592 US10155042B2 (en) 2010-10-29 2017-06-05 Compositions and methods for treating chronic inflammation and inflammatory diseases
US15/684,214 US10213381B2 (en) 2010-10-29 2017-08-23 Solid solution compositions and use in chronic inflammation
US15/684,197 US10363232B2 (en) 2010-10-29 2017-08-23 Compositions and methods for treating severe pain
US15/702,440 US10231943B2 (en) 2010-10-29 2017-09-12 Compositions and methods for treating cardiovascular diseases
US15/794,178 US10188619B2 (en) 2010-10-29 2017-10-26 Solid solution compositions and use in chronic inflammation
US15/794,197 US10154975B2 (en) 2010-10-29 2017-10-26 Solid solution compositions and use in chronic inflammation
US15/794,214 US10143671B2 (en) 2010-10-29 2017-10-26 Solid solution compositions and use in chronic inflammation
US16/012,036 US10426748B2 (en) 2010-10-29 2018-06-19 Compositions and methods for treating chronic inflammation and inflammatory diseases
US16/166,272 US10596132B2 (en) 2010-10-29 2018-10-22 Solid solution compositions and use in chronic inflammation
US16/206,789 US10653778B2 (en) 2010-10-29 2018-11-30 Compositions and methods for treating chronic inflammation and inflammatory diseases
US16/206,814 US10588878B2 (en) 2010-10-29 2018-11-30 Solid solution compositions and use in chronic inflammation
US16/284,221 US10835490B2 (en) 2010-10-29 2019-02-25 Solid solution compositions and use in chronic inflammation
US16/525,520 US10857114B2 (en) 2010-10-29 2019-07-29 Compositions and methods for treating severe pain
US16/573,776 US10849869B2 (en) 2010-10-29 2019-09-17 Compositions and methods for treating chronic inflammation and inflammatory diseases
US16/729,363 US20200129461A1 (en) 2010-10-29 2019-12-28 Compositions Comprising Cancer Drug-Fatty Acid Conjugates
US16/818,668 US11000493B2 (en) 2010-10-29 2020-03-13 Solid solution compositions and use in chronic inflammation
US16/882,663 US11154500B2 (en) 2010-10-29 2020-05-25 Solid solution compositions and use in chronic inflammation
US16/882,667 US11224659B2 (en) 2010-10-29 2020-05-25 Solid solution compositions and use in severe pain
US16/882,666 US11202831B2 (en) 2010-10-29 2020-05-25 Solid solution compositions and use in cardiovascular disease
US17/107,724 US11660276B2 (en) 2010-10-29 2020-11-30 Compositions and methods for treating chronic inflammation and inflammatory diseases
US17/113,476 US11730709B2 (en) 2010-10-29 2020-12-07 Compositions and methods for treating severe pain
US17/146,989 US11103472B2 (en) 2010-10-29 2021-01-12 Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)
US17/146,950 US11065218B2 (en) 2010-10-29 2021-01-12 Compositions and methods for treating chronic inflammation and inflammatory diseases
US17/230,855 US11844773B2 (en) 2010-10-29 2021-04-14 Solid solution compositions and use in chronic inflammation
US17/378,744 US20210338617A1 (en) 2010-10-29 2021-07-18 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
US17/448,263 US11992555B2 (en) 2010-10-29 2021-09-21 Solid solution compositions and use in chronic inflammation
US17/540,802 US11826428B2 (en) 2010-10-29 2021-12-02 Solid solution compositions comprising cannabidiols
US17/646,241 US11918654B2 (en) 2010-10-29 2021-12-28 Solid solution compositions and use in severe pain
US18/509,114 US12533332B2 (en) 2010-10-29 2023-11-14 Compositions and methods for treating chronic inflammation and inflammatory diseases
US18/595,716 US20240207408A1 (en) 2010-10-29 2024-03-05 Solid Solution Compositions and Use in Severe Pain
US18/641,775 US20240277613A1 (en) 2010-10-29 2024-04-22 Solid Solution Compositions and Use in Chronic Inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1113729.6A GB201113729D0 (en) 2011-08-10 2011-08-10 Hyperlipidaemia

Publications (1)

Publication Number Publication Date
GB201113729D0 true GB201113729D0 (en) 2011-09-21

Family

ID=44735670

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1113729.6A Ceased GB201113729D0 (en) 2010-10-29 2011-08-10 Hyperlipidaemia

Country Status (1)

Country Link
GB (1) GB201113729D0 (en)

Similar Documents

Publication Publication Date Title
DK3424953T3 (en) Terapeutiske antistoffer
DK2691417T4 (en) Antistof fc-varianter
EP2755962A4 (en) Azaindazoles
EP2754063A4 (en) Smb2 scaleout
EP2723631A4 (en) Quadfolier
EP2776444A4 (en) Dihydropteridinones
AP2014007621A0 (en) 2-Thiopyrimidinones
EP2695208A4 (en) Micro-thermocouple
DK2770906T3 (en) Applanationstonometer
GB201109024D0 (en) Can
GB201101727D0 (en) Obuoy
GB201100001D0 (en) TidySqueeze2
GB201113729D0 (en) Hyperlipidaemia
AU5026P (en) Goldstrike Agapanthus inapertus
AU5031P (en) BESYS Beschorneria yuccoides
AU4540P (en) BUNNAN Baloskion tetraphyllum
AU5171P (en) Sunparamiho Mandevilla xamabilis
AU340282S (en) Can
AP00723S1 (en) Autorickshaw
GB201101047D0 (en) VibroPred
GB201101675D0 (en) i-mc
AU2011035V (en) DBK02 Babingtonia virgata
AP2011000390S (en) Kuppkraft
AU338110S (en) Barstool
GB201100008D0 (en) Jigsawing

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)